Perforation and Stage-II Colon Cancer: Is it Always High Risk?

Por Blanke, Charles D.
Publicado em 2008

Commentary: Clinical Trials Represent the Best Cancer Care. Or Do They?

Por Blanke, Charles D.
Publicado em 2011

Gastrointestinal oncology a practical guide /

Por Blanke, Charles D., Rödel, Claus., Talamonti, Mark S.
Publicado em 2011

Effect of M1a and M1b Category in Metastatic Colorectal Cancer

Por Kennecke, Hagen, Yu, Jason, Gill, Sharlene, Cheung, Winson Y., Blanke, Charles D., Speers, Caroline, Woods, Ryan
Publicado em 2014

Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II Southwest Oncology Group Study (S0415)

Por Gold, Philip J., Goldman, Bryan, Iqbal, Syma, Leichman, Lawrence P., Zhang, Wu, Lenz, Heinz-Josef, Blanke, Charles D.
Publicado em 2010

The Scientific Impact of Positive and Negative Phase III Cancer Clinical Trials

Por Unger, Joseph M., Barlow, Willliam E., Ramsey, Scott D., LeBlanc, Michael, Blanke, Charles D., Hershman, Dawn L.
Publicado no JAMA Oncol (2016)

S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors

Por Blanke, Charles D., Rankin, Cathy, Corless, Christopher, Eary, Janet F., Mulder, Karen, Okuno, Scott H., George, Suzanne, Heinrich, Michael
Publicado no Oncologist (2015)

KRAS and Colorectal Cancer: Ethical and Pragmatic Issues in Effecting Real-Time Change in Oncology Clinical Trials and Practice

Por Blanke, Charles D., Goldberg, Richard M., Grothey, Axel, Mooney, Margaret, Roach, Nancy, Saltz, Leonard B., Welch, John J., Wood, William A., Meropol, Neal J.
Publicado em 2011

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

Por Blanke, Charles D., Bot, Brian M., Thomas, David M., Bleyer, Archie, Kohne, Claus-Henning, Seymour, Matthew T., de Gramont, Aimery, Goldberg, Richard M., Sargent, Daniel J.
Publicado no J Clin Oncol (2011)

S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach

Por Blanke, Charles D., Chansky, Kari, Christman, Kathy L., Hundahl, Scott A., Issell, Brian F., Van Veldhuizen, Peter J., Budd, G Thomas, Abbruzzese, James L., Macdonald, John S.
Publicado em 2010

Phase II Trial of Depsipeptide (NSC-630176) in Previously Treated Colorectal Cancer Patients with Advanced Disease: A Southwest Oncology Group Study (S0336)

Por Whitehead, Robert P., Rankin, Cathryn, Hoff, Paulo M.G., Gold, Philip J., Billingsley, Kevin G., Chapman, Robert A., Wong, Lucas, Ward, John H., Blanke, Charles D.
Publicado em 2008

SWOG 0514: A phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

Por El-Khoueiry, Anthony B., Rankin, Cathryn J., Ben-Josef, Edgar, Lenz, Heinz-Josef, Gold, Philip J., Hamilton, R. Darryl, Govindarajan, Rangaswamy, Eng, Cathy, Blanke, Charles D.
Publicado em 2011

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202

Por Iqbal, Syma, Rankin, Cathryn, Lenz, Heinz-Josef, Gold, Philip J., Ahmad, Syed A., El-Khoueiry, Anthony B., Messino, Michael J., Holcombe, Randall F., Blanke, Charles D.
Publicado em 2011

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (INT-0144; SWOG 9304)

Por Ulrich, Cornelia M., Rankin, Cathryn, Toriola, Adetunji T., Makar, Karen W., Altug-Teber, Özge, Benedetti, Jacqueline K., Holmes, Rebecca S., Smalley, Stephen R., Blanke, Charles D., Lenz, Heinz-Josef
Publicado no Cancer (2014)

Gene Expression Signatures and Response to Imatinib Mesylate in Gastrointestinal Stromal Tumor

Por Rink, Lori, Skorobogatko, Yuliya, Kossenkov, Andrew, Belinsky, Martin G., Pajak, Thomas, Heinrich, Michael C., Blanke, Charles D., von Mehren, Margaret, Ochs, Michael F., Eisenberg, Burton, Godwin, Andrew K.
Publicado em 2009

CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414)

Por Tomblyn, Michael B., Goldman, Bryan H., Thomas, Charles R., Benedetti, Jacqueline K., Lenz, Heinz-Josef, Mehta, Vivek, Beeker, Thaddeus, Gold, Philip J., Abbruzzese, James L., Blanke, Charles D.
Publicado em 2012

The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database

Por Cheung, Winson Y., Shi, Qian, O’Connell, Michael, Cassidy, James, Blanke, Charles D., Kerr, David J., Meyers, Jeff, Van Cutsem, Eric, Alberts, Steven R., Yothers, Greg, Sargent, Daniel J.
Publicado em 2013

Dual blockade of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: phase Ib and randomized phase...

Por Philip, Philip A., Goldman, Bryan, Ramanathan, Ramesh K., Lenz, Heinz-Josef, Lowy, Andrew M., Whitehead, Robert P., Wakatsuki, Takeru, Iqbal, Syma, Gaur, Rakesh, Benedetti, Jacqueline K., Blanke, Charles D.
Publicado no Cancer (2014)

The Globalization of Cooperative Groups

Por Valdivieso, Manuel, Corn, Benjamin W., Dancey, Janet E., Wickerham, D. Lawrence, Horvath, L. Elise, Perez, Edith A., Urton, Alison, Cronin, Walter M., Field, Erica, Lackey, Evonne, Blanke, Charles D.
Publicado no Semin Oncol (2015)

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radi...

Por Wang, Dian, Zhang, Qiang, Blanke, Charles D., Demetri, George D., Heinrich, Michael C., Watson, James C., Hoffman, John P., Okuno, Scott, Kane, John M., von Mehren, Margaret, Eisenberg, Burton L.
Publicado em 2011